Veille documentaire MTPH

Auteur       Justin P. Albertson
Auteur       Whitney J. Clegg
Auteur       Heather D. Reid
Auteur       Benjamin S. Arbise
Auteur       Julie Pryde
Auteur       Awais Vaid
Auteur       Rachella Thompson-Brown
Auteur       Fredrick Echols
Volume       65
Numéro       29
Pages       731-734
Publication       MMWR. Morbidity and mortality weekly report
ISSN       1545-861X
Date       Jul 29, 2016
Résumé       Mumps is an acute viral disease characterized by fever and swelling of the parotid or other salivary glands. On May 1, 2015, the Illinois Department of Public Health (IDPH) confirmed a mumps outbreak at the University of Illinois at Urbana-Champaign. IDPH and the Champaign-Urbana Public Health District (C-UPHD) conducted an investigation and identified 317 cases of mumps during April 2015-May 2016. Because of sustained transmission in a population with high 2-dose coverage with measles-mumps-rubella (MMR) vaccine, a third MMR dose was recommended by IDPH, C-UPHD, and the university’s McKinley Health Center. No formal recommendation for or against the use of a third MMR dose has been issued by the Advisory Committee on Immunization Practices (ACIP) (1). However, CDC has provided guidelines for use of a third dose as a control measure during mumps outbreaks in settings in which persons are in close contact with one another, where transmission is sustained despite high 2-dose MMR coverage, and when traditional control measures fail to slow transmission (2).